Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of Digestive Diseases|August 29, 2015
Variations in inflammatory genes as molecular markers for prediction of inflammatory bowel disease occurrenceBiljana Stankovic, Sanja Dragasevic, Dragan Popovic, et al.
European Journal of Gastroenterology & Hepatology|April 29, 2017
Genetic and environmental factors significant for the presentation and development of inflammatory bowel diseaseSanja Dragasevic, Biljana Stankovic, Tomica Milosavljevic, et al.
Journal of Medical Biochemistry|January 2, 2019
Variants in TPMT, ITPA, ABCC4 and ABCB1 Genes As Predictors of 6-mercaptopurine Induced Toxicity in Children with Acute Lymphoblastic LeukemiaGoran Milosevic, Nikola Kotur, Nada Krstovski, et al.
Frontiers in Genetics|August 1, 2022
Genome-Wide Association Study of COVID-19 Outcomes Reveals Novel Host Genetic Risk Loci in the Serbian PopulationMarko Zecevic, Nikola Kotur, Bojan Ristivojevic, et al.
Metabolic Syndrome and Related Disorders|November 22, 2019
Metabolic Syndrome in Inflammatory Bowel Disease: Association with Genetic Markers of Obesity and InflammationSanja Dragasevic, Biljana Stankovic, Nikola Kotur, et al.
Clinical Immunology (Orlando, Fla.)|September 9, 2018
Importance of TLR9-IL23-IL17 axis in inflammatory bowel disease development: Gene expression profiling studySanja Dragasevic, Biljana Stankovic, Aleksandra Sokic-Milutinovic, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 18, 2025
NLRP3 promoter methylation as a predictive biomarker for glucocorticoid response in patients with inflammatory bowel diseaseGiulia Zudeh, Davide Selvestrel, Matteo Bramuzzo, et al.
Journal of Medical Biochemistry|June 4, 2019
Expression Pattern of Long Non-coding RNA Growth Arrest-specific 5 in the Remission Induction Therapy in Childhood Acute Lymphoblastic LeukemiaVladimir Gasic, Biljana Stankovic, Branka Zukic, et al.
International Journal of Molecular Sciences|February 13, 2025
High Expression Levels of the Long Non-Coding RNAs Lnc-IRF2-3 and Lnc-KIAA1755-4 Are Markers of Poor Prognosis in Chronic Lymphocytic LeukemiaNatasa Tosic, Kristina Tomic Vujovic, Vojin Vukovic, et al.
Biomedicines|January 28, 2026
Pharmacogenomic Pathways Underlying Variable Vedolizumab Response in Crohn's Disease Patients: A Rare-Variant AnalysisBiljana Stankovic, Mihajlo Stasuk, Vladimir Gasic, et al.
Pageof 4